Browse MedTech Investors in the United States
Active investors with offices in United States — sourced from recent funding rounds.
Every investor on the site in one downloadable file · CSV + Excel
.406 Ventures
Boston-based early-stage VC focused on healthcare, data and AI, and cybersecurity. Partners with founders from first check through category-defining scale.
AbbVie Ventures
Corporate VC arm of AbbVie investing in early-stage biotech targeting oncology, immunology, neuroscience, eye care, and aesthetics.
Able Partners
Early-stage consumer fund investing in health, wellness, and mental health brands targeting the gap between GDP growth and wellbeing.
Accrete Health Partners
Venture and innovation platform of Bon Secours Mercy Health that invests in, builds, and partners with digital health companies across patient engagement, data, and AI.
Acumen America
Pre-seed and seed VC investing in mission-driven founders building solutions to health inequity, financial instability, and workforce barriers for low-income Americans.
age1
Early-stage VC fund backing contrarian founders building therapeutics, tools, and technologies targeting aging and age-related disease
Alexandria Venture Investments
Corporate VC arm of Alexandria Real Estate Equities investing in life science, agrifoodtech, and climate innovation companies from seed to growth stage
Allumia Ventures
US-focused healthcare VC backing commercial-stage digital health, tech-enabled services, and MedTech companies at Series A–C. Spun out from Providence Ventures in 2025.
Amed Ventures
Bay Area VC backing early-stage MedTech founders, pairing capital with hands-on operational support from operators with corporate track records.
American Cancer Society BrightEdge
Donor-funded venture arm of the American Cancer Society investing in early-stage oncology therapeutics, diagnostics, devices, and health equity technologies.
Amgen Ventures
Corporate venture arm of Amgen investing in early-stage biotech and digital health companies across oncology, neuroscience, inflammation, and emerging therapeutic platforms.
AMR Action Fund
The world's largest VC fund exclusively investing in clinical-stage biotech developing new antibiotics and antimicrobials for drug-resistant pathogens.
Skip the browsing. Get every investor in one sheet.
Filter by stage, sector and location in Excel or Google Sheets · Website, offices, stages, sectors, founded year, portfolio link, notes · CSV + Excel
Get the Complete Investor Database →Amzak Health
Evergreen fund investing in medtech and biotech companies from early stage through commercialization, targeting first-in-class or best-in-class treatments for unmet medical needs.
Artesian Venture Partners
Global alternative investment firm specializing in debt, VC, and impact strategies.
Asahi Kasei CVC
Corporate VC arm of Asahi Kasei investing globally across all stages in materials, homes, healthcare, IoT, energy, and sustainability startups.
Ascension Ventures
Strategic healthcare venture investing in transformative solutions
Astellas Venture Management
Wholly-owned CVC arm of Astellas Pharma investing in private early-stage biotech companies developing therapeutics and platform technologies at preclinical stage.
Astoria Health Investors
Venture capital firm focused on late-stage and growth investments in healthcare and medical technology companies, based in Las Vegas.
Atma Capital
Investor backing deep science founders in life sciences, digital technology, and sustainability to address universal health and intelligence challenges.
Aulis Capital
Investing in founders redefining the future of healthcare and medical technology
Avego BioScience Capital
Healthcare investors focusing on mid-to-late stage life sciences ventures.
Bayless Ventures
Early-stage VC focused on digital health and technology-enabled healthcare services, investing up to $250K at pre-seed and seed with a focus on underrepresented founders.
Big Red Ventures (BRV)
One of the oldest student-run VC funds, operated entirely by Cornell MBA students investing up to $25K in early-stage, industry-agnostic US startups.
BioAdvance
Evergreen seed and Series A fund backing early-stage life science companies across therapeutics, medical devices, digital health, and diagnostics in the Mid-Atlantic corridor.
Showing 1–24 of 190 investors
This list has 190 investors. The complete database has every investor on the site.
Get every investor in one sheet. Filter by stage, sector and location in Excel or Google Sheets · Website, offices, stages, sectors, founded year, portfolio link, notes · CSV + Excel
Get the Complete Investor Database →